+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Multiple organ dysfunction syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Multiple organ dysfunction syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Noonan Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Noonan Syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Perennial Allergic Rhinitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Perennial Allergic Rhinitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Treg cell-based Therapies - Epidemiology Forecast - 2032 - Product Thumbnail Image

Treg cell-based Therapies - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
MOG Antibody Disease - Epidemiology Forecast - 2032 - Product Thumbnail Image

MOG Antibody Disease - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Human Immunodeficiency Virus Type 1 (HIV-1) Infection - Epidemiology Forecast - 2032 - Product Thumbnail Image

Human Immunodeficiency Virus Type 1 (HIV-1) Infection - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Von Hippel-Lindau (VHL) Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Von Hippel-Lindau (VHL) Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Drug Hypersensitivity - Epidemiology Forecast - 2032 - Product Thumbnail Image

Drug Hypersensitivity - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Xlinked Severe Combined Immunodeficiency (SCID) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Xlinked Severe Combined Immunodeficiency (SCID) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Sporadic Inclusion Body Myositis (sIBM) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Sporadic Inclusion Body Myositis (sIBM) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
HIV (Human Immunodeficiency Virus) - Epidemiology Forecast - 2032 - Product Thumbnail Image

HIV (Human Immunodeficiency Virus) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Steroid Refactory Acute Graft-Versus-Host Disease (GVHD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Steroid Refactory Acute Graft-Versus-Host Disease (GVHD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Inclusion Body Myositis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Inclusion Body Myositis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Acquired Immunodeficiency Syndrome (AIDS) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Acquired Immunodeficiency Syndrome (AIDS) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cutaneous Lupus Erythematosus (CLE) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cutaneous Lupus Erythematosus (CLE) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Systemic Inflammatory Response Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Systemic Inflammatory Response Syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
tenosynovitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

tenosynovitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Eosinophilic Disorder - Epidemiology Forecast to 2032 - Product Thumbnail Image

Eosinophilic Disorder - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Wiskott-Aldrich Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Wiskott-Aldrich Syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Sanfilippo Syndrome Type A (MPS IIIA) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Sanfilippo Syndrome Type A (MPS IIIA) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more